These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25640820)

  • 1. Single-entity heparan sulfate glycomimetic clusters for therapeutic applications.
    Tyler PC; Guimond SE; Turnbull JE; Zubkova OV
    Angew Chem Int Ed Engl; 2015 Feb; 54(9):2718-23. PubMed ID: 25640820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a targeted library of heparan sulfate hexa- to dodecasaccharides as inhibitors of β-secretase: potential therapeutics for Alzheimer's disease.
    Schwörer R; Zubkova OV; Turnbull JE; Tyler PC
    Chemistry; 2013 May; 19(21):6817-23. PubMed ID: 23553710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise chemoenzymatic synthesis of heparan sulfate analogues as potent BACE-1 inhibitors.
    Li J; Li J; Sun T; Cai C; Shao M; Yu G
    Carbohydr Polym; 2019 Aug; 217():232-239. PubMed ID: 31079681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase.
    Scholefield Z; Yates EA; Wayne G; Amour A; McDowell W; Turnbull JE
    J Cell Biol; 2003 Oct; 163(1):97-107. PubMed ID: 14530380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer Therapy.
    Zubkova OV; Ahmed YA; Guimond SE; Noble SL; Miller JH; Alfred Smith RA; Nurcombe V; Tyler PC; Weissmann M; Vlodavsky I; Turnbull JE
    ACS Chem Biol; 2018 Dec; 13(12):3236-3242. PubMed ID: 30480427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel heparan sulphate analogues: inhibition of beta-secretase cleavage of amyloid precursor protein.
    Patey SJ; Yates EA; Turnbull JE
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1116-8. PubMed ID: 16246059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfates demonstrate potential for Alzheimer’s disease therapy.
    Hill R
    Future Med Chem; 2013 Jul; 5(11):1190. PubMed ID: 24020082
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of heparan sulfate in the generation of Abeta.
    Patey SJ
    Drug News Perspect; 2006 Sep; 19(7):411-6. PubMed ID: 17080204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low anticoagulant heparin oligosaccharides as inhibitors of BACE-1, the Alzheimer's β-secretase.
    Zhang X; Zhao X; Lang Y; Li Q; Liu X; Cai C; Hao J; Li G; Yu G
    Carbohydr Polym; 2016 Oct; 151():51-59. PubMed ID: 27474542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin derivatives as inhibitors of BACE-1, the Alzheimer's beta-secretase, with reduced activity against factor Xa and other proteases.
    Patey SJ; Edwards EA; Yates EA; Turnbull JE
    J Med Chem; 2006 Oct; 49(20):6129-32. PubMed ID: 17004727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of proBACE1 by glycosaminoglycans.
    Small DH; Klaver DW; Beckman M
    Neurodegener Dis; 2008; 5(3-4):206-8. PubMed ID: 18322391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
    Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.
    Choi SJ; Cho JH; Im I; Lee SD; Jang JY; Oh YM; Jung YK; Jeon ES; Kim YC
    Eur J Med Chem; 2010 Jun; 45(6):2578-90. PubMed ID: 20303626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
    Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
    Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of BACE1 inhibition of tripartite structures by modification of membrane anchors, spacers and pharmacophores - development of potential agents for the treatment of Alzheimer's disease.
    Linning P; Haussmann U; Beyer I; Weidlich S; Schieb H; Wiltfang J; Klafki HW; Knölker HJ
    Org Biomol Chem; 2012 Oct; 10(41):8216-35. PubMed ID: 22930158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies.
    Liu P; Niu Y; Wang C; Sun Q; Zhai Y; Yu J; Sun J; Xu F; Yan G; Huang W; Liang L; Xu P
    Eur J Med Chem; 2014 May; 79():413-21. PubMed ID: 24763262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
    Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
    ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.
    Arungundram S; Al-Mafraji K; Asong J; Leach FE; Amster IJ; Venot A; Turnbull JE; Boons GJ
    J Am Chem Soc; 2009 Dec; 131(47):17394-405. PubMed ID: 19904943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro biological evaluation and molecular docking studies of benzimidamides as potential BACE1 inhibitors.
    Niu Y; Gao H; Xu F; Wang C; Liu P; Yang G; Sun Q; Xu P
    Chem Biol Drug Des; 2012 Nov; 80(5):775-80. PubMed ID: 22882897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
    Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.